Skip to main content
Clinical Trials/ISRCTN39062047
ISRCTN39062047
Completed
Phase 2

Intensive treatment for periodontal disease: A model of and therapy for inflammatory vascular dysfunction

niversity College London (UK)0 sites284 target enrollmentFebruary 25, 2014

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Topic: Oral and Gastrointestinal
Sponsor
niversity College London (UK)
Enrollment
284
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 25, 2014
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity College London (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Subject must be \> 18 years
  • 2\. Subject must have moderate to severe PD (at least 30 periodontal pockets \>4mm with Bleeding on Probing)
  • 3\. Subject must have voluntarily signed the informed consent

Exclusion Criteria

  • 1\. Female subject is pregnant or lactating or of childbearing and not using acceptable methods of birth control
  • 2\. Subject is on chronic treatment (i.e., two weeks or more) with specific medications known to affect periodontal status (phenytoin or cyclosporine) within one month of baseline visit
  • 3\. Subject knowingly has HIV or Hepatitis
  • 4\. Subject has limited mental capacity or language skills such that simple instructions cannot be followed or information regarding adverse events cannot be provided
  • 5\. Subjects on chronic antibiotic therapy or who require antibiotic coverage for periodontal procedures
  • 6\. Subjects had a course of periodontal therapy in the preceding 6 month

Outcomes

Primary Outcomes

Not specified

Similar Trials